7-65398443-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152626.4(ZNF92):āc.329A>Gā(p.Asn110Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000254 in 1,613,050 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152626.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF92 | ENST00000328747.12 | c.329A>G | p.Asn110Ser | missense_variant | 4/4 | 1 | NM_152626.4 | ENSP00000332595.8 | ||
ZNF92 | ENST00000357512.3 | c.233A>G | p.Asn78Ser | missense_variant | 3/3 | 1 | ENSP00000350113.2 | |||
ZNF92 | ENST00000450302.2 | c.122A>G | p.Asn41Ser | missense_variant | 3/3 | 1 | ENSP00000396126.2 | |||
ZNF92 | ENST00000431504.1 | c.101A>G | p.Asn34Ser | missense_variant | 2/2 | 1 | ENSP00000400495.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152136Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250748Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135574
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1460914Hom.: 0 Cov.: 31 AF XY: 0.0000179 AC XY: 13AN XY: 726764
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152136Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74322
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.329A>G (p.N110S) alteration is located in exon 4 (coding exon 4) of the ZNF92 gene. This alteration results from a A to G substitution at nucleotide position 329, causing the asparagine (N) at amino acid position 110 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at